Skip to main content
Log in

Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Experimental chronic renal insufficiency (produced by 5/6 ablation of renal parenchyma) is associated with changes in the kinetics of oral (intragastric) cyclosporine A (CyA). Compared with animals with intact renal parenchyma, significantly lower levels of CyA are reached under these conditions. The factors resonsible for reduced CyA availability under these conditions have not yet been identified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kahan B.D., Kramer W.G., Wideman S.M. et al. (1986): Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay. Transplant. Proc., 41, 459–464.

    CAS  Google Scholar 

  2. Follath F., Wenk M., Vozeh S. (1983): Intravenous cyclosporine kinetics in renal failure. Clin. Pharmacol. Ther., 34, 638.

    CAS  PubMed  Google Scholar 

  3. Buckart G.J., Starzl T.E., Venkataramenan R. et al. (1986): Excretion of cyclosporine and its metabolites in human bile. Transplant. Proc., 18 (Suppl 5), 46–49.

    Google Scholar 

  4. Grevel J. (1988): Significance of cyclosporine pharmacokinetics. Transplant. Proc., 20 (Suppl. 2), 428–434.

    CAS  PubMed  Google Scholar 

  5. Bohdanecká M., Schück O., Petrásek R. et al. (1995): Experimental modeling of the effect of uremia on cyclosporin A bioavailability. Int. J. Clin. Pharmacol. Ther., 33, 61.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schück, O., Bohdanecká, M., Šedivý, J. et al. Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma. European Journal of Drug Metabolism and Pharmacokinetics 22, 207–209 (1997). https://doi.org/10.1007/BF03189808

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189808

Keywords

Navigation